Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck.
Saved in:
| Title: | Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck. |
|---|---|
| Authors: | Akbaba S; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany., Mock A; Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg, German Cancer Research Center, Heidelberg, Germany., Hoerner-Rieber J; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany., Held T; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany., Katayama S; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany., Forster T; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany., Freudlsperger C; Department of Oral and Maxillofacial Surgery, Heidelberg University Hospital, Heidelberg, Germany., Rieken S; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany., Herfarth K; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Plinkert P; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany., Debus J; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Adeberg S; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Institute of Radiation Oncology, Heidelberg, Germany.; National Center for Tumor Diseases, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2019 Aug 13; Vol. 9, pp. 755. Date of Electronic Publication: 2019 Aug 13 (Print Publication: 2019). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2019.00755 |
